RFCL Overview
- Founded
-
2005

- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
- Investments
-
3
RFCL General Information
Description
Provider of vitro diagnostics, animal healthcare, custom synthesis, and laboratory solutions. The company offers products for diabetes, hematology, infectious diseases, women healthcare, and routine chemistry; and laboratory reagents, imported chemicals, filtration and chromatography products, certified reference standards, liquid handling, and biopharmaceutical products.
Contact Information
Website
www.rfcl.in
Formerly Known As
Ranbaxy Fine Chemicals Limited
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Acquirer
Primary Office
- A-Three, Okhla Industrial Area
- Phase One
- New Delhi, 110020
- India
+91 011 0000 0000
RFCL Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
RFCL Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Bharat Bhatnagar | General Manager, Sales | ||
R. Govindan | Vice President |
RFCL Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
RFCL Investments (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 000000 | 31-Mar-2008 | 0000000000 | Pharmaceuticals | ||
00000 000000 | 24-Jul-2007 | 0000000000 | BPO/Outsource Services | 000000 00 | |
Vetnex Animal Health | Buyout/LBO | Pharmaceuticals |
RFCL Exits (2)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000 000000 | 31-Mar-2008 | 0000000000 | Completed |
|
|
Vetnex Animal Health | Buyout/LBO | Completed |
|